NOVATO, Calif., April 25, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) — Collective Audience, Inc. (NASDAQ-GM: CAUD), a leading innovator of audience-based performance advertising […]
TAMPA, Fla., April 25, 2024 (GLOBE NEWSWIRE) — Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated, […]